About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Targeting Mitochondrial Lipids Could Pave the Way to Therapies for Parkinson's Disease

by Dr. Trupti Shirole on February 13, 2017 at 6:15 AM
Font : A-A+

Targeting Mitochondrial Lipids Could Pave the Way to Therapies for Parkinson's Disease

An estimated 10 million people are currently affected by Parkinson's disease worldwide. A small percentage gets confronted with the disease before the age of 40.

While the causes of the affected are not yet known, scientists believe that they consist of both genetic and environmental factors. In genetic Parkinson's disease, a mutation in the PINK1 gene causes changes in neurons' mitochondria, leading to the degeneration of these neurons.

Advertisement


A team of researchers led by Patrik Verstreken (VIB-KU Leuven) have identified an underlying mechanism in early onset Parkinson's. Using flies, mice and patient cells, the team focused on cardiolipin, a fat unique to cells' mitochondria, organelles that produce energy.

They demonstrated that reducing the effects of the protein FASN influences the mitochondria, leading to increased cardiolipin levels and reduced Parkinson's symptoms. These results could pave the way to therapies for Parkinson's disease that target lipids. The team's research was published in the scientific magazine Journal of Cell Biology.
Advertisement

Existing oncological applications

In this study, prof. Verstreken and his team, consisting of collaborators in Belgium, Germany and Portugal, observed that a protein responsible for lipid creation in cells, FASN, bypasses the genetic defect in mitochondria.

Prof. Patrik Verstreken (VIB-KU Leuven): "Several drugs that block FASN already exist, as this protein is also important to cancer research and treatment. Many of them have already been used in clinical trials. Thanks to this research, we can now test them in the context of Parkinson's disease."

Unexpected effects of FASN protein

In the course of their research, the researchers encountered a surprising observation. Using fly, mouse and human cell models, they saw that FASN has a direct effect on mitochondria, which have their own separate genomes and operate as energy producing entities within their cells.

Prof. Patrik Verstreken (VIB-KU Leuven): "The PINK1 gene encodes the PINK1 protein, and mutations in it lead to lower levels of cardiolipin in mitochondria. It was unexpected to see that blocking FASN - which is not localized to the mitochondria - actually sidesteps the mitochondrial effects of the PINK1 mutation. As a result, blocking FASN increases the amounts of a specific type of lipids in mitochondria, reducing the degradation of neurons."

Translating insights into therapies

Prof. Verstreken has already identified several targets for future research projects seeking greater insights into the link between the amounts of specific lipids in neurons and Parkinson's disease.

Prof. Patrik Verstreken (VIB-KU Leuven): "Some questions need to be answered before new therapies can be developed, such as 'is there a link between early onset Parkinson's prevalence and progression with lipid content?' And while we successfully demonstrated that cardiolipin can improve the function of mitochondria in flies, mouse models and in human cells, we need to explore its effects in actual patients."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cholesterol Cholesterol - The Enigma Chemical Low Saturated Fat and Low Cholesterol Diet Lipid Profile Screening Top Foods to Lower Triglycerides Cholesteryl Ester Storage Disease Dyslipidemia Lipid Profile 

Most Popular on Medindia

Hearing Loss Calculator Selfie Addiction Calculator The Essence of Yoga Diaphragmatic Hernia Noscaphene (Noscapine) Blood Donation - Recipients Sanatogen Iron Intake Calculator Daily Calorie Requirements Accident and Trauma Care
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Targeting Mitochondrial Lipids Could Pave the Way to Therapies for Parkinson's Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests